Skip to main content
Fig. 3 | The Journal of Headache and Pain

Fig. 3

From: Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials

Fig. 3

Proportion of participants “satisfied” or “extremely satisfied” with study medication at 2 and 24 h after initial dose in (a) TIR and (b) TIR due to insufficient efficacy groups. OR, odds ratio; TIR, triptan insufficient responder. P-values are based on logistic regression with treatment group, use of medication for migraine prevention, and baseline headache severity as covariates

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us